BRAIN Biotech AG Income Statement

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Revenue	50.22	55.5	56.23	50.3	39.22
Other Revenue	-	0	-	-	-
Revenue	50.22	55.5	56.23	50.3	39.22
Revenue Growth (YoY)	-9.52%	-1.29%	11.79%	28.23%	0.40%
Cost of Revenue	22.12	24.94	25.8	22.69	17.4
Gross Profit	28.1	30.56	30.42	27.61	21.82
Selling, General & Admin	22.57	26.36	23.34	23.06	20.5
Other Operating Expenses	8.16	8.39	7.99	6.59	4.69
Operating Expenses	35.85	39.58	35.98	33.99	29.21
Operating Income	-7.76	-9.01	-5.56	-6.38	-7.39
Interest Expense	-2.21	-1.94	-0.86	-0.53	-0.52
Interest & Investment Income	-	-	-	0	0.01
Earnings From Equity Investments	-0.53	-0.5	-1.49	-2.43	-1.72
Currency Exchange Gain (Loss)	0.21	-0.11	-0.06	0.12	-0.04
Other Non Operating Income (Expenses)	-2.02	0.52	0.09	0.28	3.98
EBT Excluding Unusual Items	-12.3	-11.04	-7.89	-8.93	-5.68
Merger & Restructuring Charges	-	-	-0.28	-0.48	-0.31
Gain (Loss) on Sale of Investments	-	-	0.54	2.36	0.58
Gain (Loss) on Sale of Assets	-	-	-	0.65	-
Other Unusual Items	0.27	0.05	0.13	0.24	1.14
Pretax Income	-12.02	-10.99	-7.49	-6.17	-4.28
Income Tax Expense	-0.19	0.11	0.63	0.18	0.4
Earnings From Continuing Operations	-11.83	-11.1	-8.11	-6.34	-4.68
Minority Interest in Earnings	0.09	-0.03	-0.17	-0.25	-0.29
Net Income	-11.74	-11.13	-8.28	-6.59	-4.97
Net Income to Common	-11.74	-11.13	-8.28	-6.59	-4.97
Shares Outstanding (Basic)	22	22	22	22	20
Shares Outstanding (Diluted)	22	22	22	22	20
Shares Change (YoY)	-	-	-	9.55%	6.89%
EPS (Basic)	-0.54	-0.51	-0.38	-0.30	-0.25
EPS (Diluted)	-0.54	-0.51	-0.38	-0.30	-0.25
Free Cash Flow	-10.77	-5.14	-6.84	-7.29	-5.16
Free Cash Flow Per Share	-0.49	-0.23	-0.31	-0.33	-0.26
Gross Margin	55.95%	55.07%	54.11%	54.89%	55.63%
Operating Margin	-15.45%	-16.24%	-9.89%	-12.69%	-18.84%
Profit Margin	-23.38%	-20.05%	-14.72%	-13.10%	-12.68%
Free Cash Flow Margin	-21.44%	-9.25%	-12.16%	-14.49%	-13.15%
EBITDA	-4.35	-5.73	-2.39	-3.27	-4.1
EBITDA Margin	-8.67%	-10.32%	-4.25%	-6.51%	-10.45%
D&A For EBITDA	3.4	3.29	3.18	3.11	3.29
EBIT	-7.76	-9.01	-5.56	-6.38	-7.39
EBIT Margin	-15.45%	-16.24%	-9.89%	-12.69%	-18.84%
Revenue as Reported	51.59	55.52	57.14	53.07	40.73

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.